via University of Reading
An antioxidant drug reverses atherosclerosis and could be used to prevent heart attacks and strokes due to clots, according to research funded by the British Heart Foundation (BHF) and published today in JAHA: Journal of the American Heart Association.
Atherosclerosis is the build-up of fatty deposits in the arteries. When a type of fat called LDL cholesterol becomes oxidised and builds up to form plaques in the artery walls, inflammation and damage increase which can cause the plaques to rupture and cause blood to clot.
These clots can block vital arteries that allow blood to flow to the heart, causing a heart attack, or to the brain causing a stroke.
Previously, researchers at the University of Reading discovered that LDL cholesterol can be oxidised in acidic small ‘bags’ called lysosomes in immune cells within the artery wall.
Now, Professor David Leake and his team have found that the antioxidant drug, cysteamine, has the power to switch off, and even reverse, this damaging process.
Cysteamine works by accumulating in the lysosomes and stops the oxidation of LDL cholesterol. It is already known to be safe in humans where it’s used to treat a rare lysosomal disease called cystinosis.
When the researchers looked at mice with atherosclerosis, those treated with cysteamine had a 32 to 56 per cent reduction in the size of atherosclerotic plaques depending on the part of the aorta – the largest artery in the body – that was examined.
Cysteamine decreased the amount of oxidised fat by 73 per cent and increased the stability of the atherosclerotic areas. It decreased the proportion of inflammatory white blood cells by 55 per cent and increased the area made up of smooth muscle cells by 85 per cent, ultimately reducing the chance of plaques rupturing and causing a blood clot.
Antioxidant drugs that have previously produced promising results in mice have proven disappointing in clinical trials to treat cardiovascular disease, but the researchers hope that with these promising results, cysteamine will prove a successful treatment in humans.
Professor David Leake, Professor of Biomedical Sciences at the University of Reading who led the study said:
“The potential in this drug to protect against heart attacks and strokes and ultimately save lives superseded our expectations. We hoped it would cause plaques to grow at a slower pace, but we were amazed to find it reversed the process.
“Cysteamine would offer an entirely new way of treating atherosclerosis. We now want to look at the most efficient way to give this drug to patients, and hope that it can be taken to clinical trials in the next few years.”
Professor James Leiper, Associate Medical Director at the British Heart Foundation, which funded the research said:
“Heart attacks and strokes threaten the lives of people too often. In the UK, every 5 minutes someone is admitted to hospital with a heart attack, and the same is true of stroke. “The more ways we can find to treat the root cause of cardiovascular disease, the more lives and livelihoods that can be saved.
“If this antioxidant drug can show the same promising effects in humans, then it could offer a lifeline to thousands of people in the future.”
Original Article: ANTIOXIDANT DRUG REVERSES PROCESS RESPONSIBLE FOR HEART ATTACKS AND STROKES
More from: University of Reading
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Cysteamine
- Early Detection of Huntington's Diseaseon May 7, 2024 at 5:00 pm
Odds ratios are per SD of each measure among gene-expanded Neurobiological Predictors of Huntington's Disease (PREDICT-HD) subjects. Control for age and gender had no substantial effect on the ...
- AMGEN REPORTS FIRST QUARTER 2024 FINANCIAL RESULTSon May 2, 2024 at 1:01 pm
Amgen (NASDAQ:AMGN) today announced financial results for the first quarter 2024. "With many of our innovative products delivering strong growth and promising new medicines advancing through our ...
- Thiogenesis Announces Acceptance of Clinical Trial Application - Part I in the EU for MELASon March 24, 2024 at 5:00 pm
This comes after a successful study in healthy volunteers confirmed that TTI-0102 is a prodrug of a well characterized and previously approved cysteamine-based drug. MELAS is the most common of ...
- Dermatologist-recommended skin care for people over 50on December 20, 2023 at 4:33 am
vitamin C and cysteamine. Watch out for scented products and instead look for fragrance-free versions. "Fragrance is generally irritating to the skin and can worsen dry skin," she explains.
- Here are four skincare discoveries that can help with aging, moisturizing, dark spotson December 19, 2023 at 9:52 pm
New discoveries about how cells communicate with each other to tell your melanocyte cells to make pigment has led to several new skincare products to treat dark spots, including Alastin A-Luminate ...
Go deeper with Google Headlines on:
Cysteamine
[google_news title=”” keyword=”cysteamine” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Treating atherosclerosis
- Study Finds Clogged Arteries Exacerbated by Cells Mimicking Cancer Behavioron May 12, 2024 at 7:11 pm
Columbia researchers have found cells inside clogged arteries share similarities with cancer and aggravate atherosclerosis, raising the possibility that anticancer drugs could be used to treat ...
- Atherosclerosis Progression May Share Traits With Tumor Growthon May 7, 2024 at 5:00 pm
“accelerates phenotypic switching and exacerbates atherosclerosis.” Pan and colleagues also looked at the effects of niraparib (Zejula; GlaxoSmithKline), a drug aimed at repairing DNA damage that’s ...
- Evidence Builds to Support Colchicine in Treating Atherosclerotic Cardiovascular Diseaseon May 6, 2024 at 8:32 am
Colchicine, a legacy drug that received a new indication in 2023 for cardiovascular disease, can treat arterial inflammation after a heart attack, a principal investigator of clinical trials said.
- Clogged arteries worsened by cells that behave like cancer cellson April 30, 2024 at 5:00 pm
Researchers have found that cells inside clogged arteries have cancer-like properties that aggravate atherosclerosis, and anticancer drugs could be a new treatment. -Columbia University ...
- Cancer-Like Cells Worsen Clogged Arterieson April 30, 2024 at 5:00 pm
Columbia researchers have found cells inside clogged arteries share similarities with cancer and aggravate atherosclerosis, raising the possibility that anticancer drugs could be used to treat ...
Go deeper with Google Headlines on:
Treating atherosclerosis
[google_news title=”” keyword=”treating atherosclerosis” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]